SP7

Sp7 transcription factor, the group of Zinc fingers C2H2-type|Sp transcription factors

Basic information

Region (hg38): 12:53326575-53345315

Links

ENSG00000170374NCBI:121340OMIM:606633HGNC:17321Uniprot:Q8TDD2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • osteogenesis imperfecta type 12 (Strong), mode of inheritance: AR
  • osteogenesis imperfecta type 4 (Supportive), mode of inheritance: AD
  • osteogenesis imperfecta type 12 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Osteogenesis imperfecta, type XIIARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingDental; Musculoskeletal20579626

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SP7 gene.

  • not_provided (122 variants)
  • not_specified (59 variants)
  • Osteogenesis_imperfecta_type_12 (14 variants)
  • Osteogenesis_imperfecta (9 variants)
  • SP7-related_disorder (6 variants)
  • Osteogenesis_Imperfecta,_Recessive (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SP7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001173467.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
54
clinvar
3
clinvar
59
missense
95
clinvar
4
clinvar
99
nonsense
1
clinvar
3
clinvar
4
start loss
0
frameshift
1
clinvar
1
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
0
Total 1 2 101 58 3

Highest pathogenic variant AF is 0.0000198296

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SP7protein_codingprotein_codingENST00000536324 218738
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5830.4151252250341252590.000136
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5012312530.9110.00001422739
Missense in Polyphen5976.3610.77264796
Synonymous0.352971020.9560.00000551952
Loss of Function2.56211.30.1775.34e-7133

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005840.0000584
Ashkenazi Jewish0.0007950.000795
East Asian0.00005590.0000551
Finnish0.00004710.0000464
European (Non-Finnish)0.0001880.000185
Middle Eastern0.00005590.0000551
South Asian0.000.00
Other0.0001650.000164

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional activator essential for osteoblast differentiation (PubMed:23457570). Binds to SP1 and EKLF consensus sequences and to other G/C-rich sequences (By similarity). {ECO:0000250|UniProtKB:Q8VI67, ECO:0000269|PubMed:23457570}.;
Disease
DISEASE: Osteogenesis imperfecta 12 (OI12) [MIM:613849]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI12 is an autosomal recessive form characterized by recurrent fractures, mild bone deformations, generalized osteoporosis, delayed teeth eruption, no dentinogenesis imperfecta, normal hearing, and white sclerae. {ECO:0000269|PubMed:20579626}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Role of Osx and miRNAs in tooth development;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Transcriptional regulation by RUNX2;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription (Consensus)

Recessive Scores

pRec
0.310

Intolerance Scores

loftool
0.433
rvis_EVS
-0.8
rvis_percentile_EVS
12.24

Haploinsufficiency Scores

pHI
0.320
hipred
Y
hipred_score
0.685
ghis
0.465

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.235

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sp7
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;

Zebrafish Information Network

Gene name
sp7
Affected structure
osteoblast
Phenotype tag
abnormal
Phenotype quality
composition

Gene ontology

Biological process
osteoblast differentiation;regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;hematopoietic stem cell differentiation;positive regulation of stem cell differentiation
Cellular component
nucleus;cytoplasm
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DEAD/H-box RNA helicase binding;metal ion binding